Deepened relationship with Perrigo
Avia Pharma are happy to announce that we have further deepen our relationship with Perrigo to include Dentosal, a much appreciated tooth paste, on the Nordic market.
Avia Pharma continues to expand – acquires Pharmaprim
The pharmaceutical company Avia Pharma has acquired the Swedish pharmaceutical company Pharmaprim, with a product portfolio consisting of drugs in urology, rheumatology and endocrinology.
Avia Pharma acquires two dermatology products from Perrigo
On December 31, 2019, Avia Pharma acquired the rights to ACO Karbamid and ACO Glycerol from Perrigo.
Avia Pharma signs licence agreement for Viiral
Following a strong sales increase in the current portfolio, Viiral AS have trusted Avia Pharma to launch Viiral on the Nordic market.
Avia Pharma signs license agreement for Femarelle
With a strong foot print in women’s health Avia Pharma are trusted to launch Femarelle in Finland.
More products added to the cooperation between Perrigo and Avia Pharma
Following a strong sales increase in the current portfolio, Avia Pharma and Perrigo have deepened the relationship to also include Vectavir®, Vectatone®, Oralmedic® and Predictor®.
Long term license agreement signed for Intrarosa®
Avia Pharma has signed a long-term license agreement with Endoceutics for the Nordic commercial rights to Intrarosa®.
Avia Pharma appoints Mattias Wik as Business Unit Director Women’s Health
Avia Pharma appoints Mattias Wik as Business Unit Director Oncology/Urology.
Parents prepared to pay out of pocket for vitamin D without palm oil
Currently there are two Vitamin D drops being sold on the Swedish market. ACO Vitamin D drops does not contain palm oil but the competing product does.
License agreement signed for Vectavir, Vectatone and Silence
Following a very strong sales increase for all products, Omega Pharma and Avia Pharma has decided to expand their co-operation.
